Xi Li

机构：The Fourth People's Hospital of Zibo City, The First People's Hospital of Shunde, Central Hospital of Zibo · ORCID：0000-0002-5538-9688

发表论文 144 篇 · 总被引 2578 次 · h-index 23

代表论文

• STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment (2024 · Journal of Controlled Release · 被引 49)
• Development and validation of a deep learning model for predicting postoperative survival of patients with gastric cancer (2024 · BMC Public Health · 被引 17)
• Global phylogeography and genomic characterization of blaKPC and blaNDM-positive clinical Klebsiella aerogenes isolates from China, 2016-2022 (2024 · The Science of The Total Environment · 被引 16)
• Mitochondria-Associated Membranes as Key Regulators in Cellular Homeostasis and the Potential Impact of Exercise on Insulin Resistance (2024 · International Journal of Molecular Sciences · 被引 15)
• Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022 (2024 · Emerging Microbes & Infections · 被引 15)
• Global emergence and transmission dynamics of carbapenemase-producing Citrobacter freundii sequence type 22 high-risk international clone: a retrospective, genomic, epidemiological study (2025 · The Lancet Microbe · 被引 14)